Boston, MA -- (SBWIRE) -- 08/15/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Fusion-IO, Inc.(NYSE:FIO), National Bank of Greece (ADR)(NYSE:NBG), First Bancorp (NYSE:FBP), GenMark Diagnostics, Inc (NASDAQ:GNMK)
Fusion-IO, Inc.(NYSE:FIO) shares decreased 2.76% to $10.94. The company on August 7 said its fourth-quarter loss widened to $23.8 million, or 24 cents per share, in the fourth quarter, from $2.4 million, or 3 cents per share, a year earlier. Excluding items, company posted a loss of 3 cents per share. Analysts had expected a loss of 3 cents per share on revenue of $110.2 million.
Additionally, the company on August 5 announced that its Board of Directors has appointed John F. Olsen, age 61, as a director of the company, effective August 1, 2013. Olsen served as president and chief operating officer of Business Objects, a provider of business intelligence solutions, from 2001 to 2004, before becoming a private investor.
Is FIO A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
National Bank of Greece (ADR)(NYSE:NBG) shares jumped 7.14% to $4.20. The company on June 14 said it had raised enough money from private investors in a share offering to ensure it avoids state control. NBG is the second major Greek lender to successfully recapitalise without falling under the full control of the Hellenic Financial Stability Fund (HFSF), a vehicle to rescue Greek banks under an EU/IMF bailout plan.
Is NBG A Good Buy After The Recent Price Movement? Find Out Here
First Bancorp (NYSE:FBP) shares gained 2.56% to $6.80. First BanCorp., the bank holding company for FirstBank Puerto Rico, on August 13 announced the pricing of the previously announced public underwritten offering by various stockholders of an aggregate of 28 million shares of the Corporation's common stock, $0.10 par value per share, that they currently own, at a price to the public of $6.75 per share. The United States Department of the Treasury is selling 12 million shares of Common Stock; funds affiliated with Thomas H. Lee Partners, L.P. ("THL") are selling 8 million shares of Common Stock; and funds managed by Oaktree Capital Management, L.P. are selling 8 million shares of Common Stock.
How Should Investors Trade FBP After The Recent Volatility? Get Free Report Here
GenMark Diagnostics, Inc (NASDAQ:GNMK) shares jumped 3.74% to $10.26 in the previous trading session. The company on August 13 announced the upsizing and pricing of its previously announced underwritten public offering. The size of the offering has been increased and the Company sold 7,622,000 shares of its common stock at a public offering price of $9.84 per share. All of the shares in the offering are being sold by GenMark. The offering is expected to close on August 19, 2013, subject to customary closing conditions.
How Should Investors Trade GNMK After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)